Ovarian Cancer Hemoscope Trial

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2025

Study Completion Date

July 31, 2030

Conditions
Ovarian Neoplasms
All Listed Sponsors
lead

Scripps Translational Science Institute

OTHER

NCT02811224 - Ovarian Cancer Hemoscope Trial | Biotech Hunter | Biotech Hunter